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Abstract H5N1 and H9N2 viruses are important causes
of avian influenza in China. H5N1 is typically associated
with severe to fatal disease in poultry, while H9N2 is
usually associated with mild disease. Differences in viral
virulence prompted us to investigate whether innate
immune responses would be differentially regulated fol-
lowing infection by H5N1 and H9N2 viruses. To address
this hypothesis, expression of a panel of innate immune-
related genes including IFN-a, IFN-b, Mx1, OASL, ISG12,
IFIT5, IRF7, USP18, SST, and KHSRP in immortal DF-1
cells following H5N1 and H9N2 infection was analyzed
and compared by real-time quantitative RT-PCR. Cells
infected by either virus overall exhibited a similar
expression profile for four ISGs (Mx1, OASL, ISG12, and
IFIT5), IFN-a, IFN-b, and SST gene. However, two
immune-regulatory genes (IRF7 and KHSRP) were not
responsive to highly pathogenic H5N1 infection but were
strongly up-regulated in DF-1 cells infected with low
pathogenic H9N2 infection. The subtype-dependent host
response observed in this study offers new insights into the
potential roles of IRF7 and KHSRP in control and modu-
lation of the replication and virulence of different subtypes
or strains of avian influenza A virus.
Keywords H5N1  H9N2  Innate immune-related genes 
Real-time quantitative PCR  Subtype-dependent host
response
Introduction
Avian influenza virus (AIV) can cause influenza in chick-
ens with a spectrum of clinical manifestations, ranging
from asymptomatic infection or mild respiratory syndrome
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to severe and fatal disease. Infection with highly patho-
genic AIV (HPAIV) usually leads to systemic ‘‘fowl pla-
gue’’ disease with high mortality rates. HPAIV can
disseminate to many tissues and organs following infec-
tion, including those in the cardiovascular, nervous,
respiratory, and urinary systems [1]. However, infection
with low pathogenic AIV (LPAIV) is often associated with
mild respiratory syndrome. Despite lower virulence, the
LPAIV still represents a constant and serious threat to the
worldwide poultry industry. AIV infection often results in a
virus-induced cytokine deregulation or a ‘‘cytokine storm’’
typically characterized by the presence of elevated levels of
pro-inflammatory cytokines and an interferon (IFN)
response [2, 3]. Type I IFN response (such as IFN-a and
IFN-b) represents the first signaling mechanism to be
activated by viral infection, thereby mediating a wide
variety of antiviral effects [4, 5]. In mammals, IFN-a/b
binds to IFN alpha–beta receptor (IFNAR) on the cell
surface and induces an antiviral state characterized by the
production of more than 300 IFN-stimulated proteins
(ISGs), such as Myxovirus (influenza virus) resistance 1
(Mx1), 20-50-oligoadenylate synthetase (OAS), IFN-stimu-
lated gene 15 (ISG15), IFN-stimulated gene 12 (ISG12),
interferon-induced protein with tetratricopeptide repeats
(IFIT) genes, and interferon response factor 7 (IRF7) [6].
Their antiviral functions have been well documented in
mammals recently [7] but are not fully described in chicken
cells.
Several avian homologs of ISGs and IFN regulatory
factor (IRF) proteins were identified, such as Mx1, OASL,
ISG12, IFIT5, and IRF7 [8–12]. Among them, the tran-
scription factor IRF7 plays an important role in the pro-
motion of IFN expression, creating a positive feedback
loop [13]. Ubiquitin-specific peptidase 18 (USP18) is an
interferon-stimulated gene 15-specific protease, involving
in this IFN-mediated antiviral signaling pathway [14–16].
Interactions between virus and the host occur at two
stages: the virus’s ability to gain access to the target cell for
replication, and the competition between the virus and host
cells to control the cellular protein synthesis machinery for
their respective benefits. The virus–host interaction is lar-
gely determined by the virulence factors of the pathogen
and the host immune response [17], and changes in the
extent and pattern of host gene expression may be the result
of viral replication. Several studies have been conducted
using real-time RT-PCR or microarray methods in order to
better understand the interplay between HPAIV and avian
cells [12, 18–20]. A robust IFN I-associated response was
observed in these investigations. To our knowledge, com-
parative analysis of host gene expressions in response to
LPAIV such as H9N2 and HPAIV has not been extensively
characterized.
DF-1 is a contiguous cell line of chicken embryo
fibroblasts that become spontaneously immortalized with-
out any viral or chemical treatment. They have been widely
used in avian virology research including avian influenza
viruses because of their susceptibility to virus infection [21,
22]. Here, we employed DF-1 cells to characterize and
compare differential host IFN I-associated gene responses




DF-1 cells were grown in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10 % Fetal Bovine
Serum (FBS) at 37 C with 5 % CO2. Culture medium was
changed every 2 days. Cell passaging was conducted by
digestion of cells with 0.25 % trypsin-EDTA and sub-
sequent passage to new flaks at a concentration of 105 cells
per mL. High pathogenic avian influenza virus H5N1 virus,
A/CK/China/1215/2012, was isolated from a live bird. Low
pathogenic avian influenza H9N2 subtype S2 strain
(A/chicken/Shandong/2/02) was provided by the Institute
of Poultry Science, Shandong Academy of Agricultural
Sciences. Viruses were propagated in DF-1 cells at an MOI
of 0.01 for 48 h prior to collection for preparation of virus
stocks. The medium for H9N2 virus cultivation contained
0.25 lg/mL TPCK-trypsin (Sigma, USA). All infectious
materials were handled under the biosafety level 3 (BSL-3)
condition, kindly provided by College of Veterinary
Medicine, South China Agricultural University.
Hemagglutination and TCID50 assays
The hemagglutination assay was carried out in V-bottom
96-well plates. Serial twofold dilutions of viruses (50 lL)
were mixed with an equal volume of a 1 % suspension (v/
v) of chicken erythrocytes and incubated at room temper-
ature for 30 min. Wells containing an adherent, homoge-
neous layer of erythrocytes were scored as positive. The
TCID50 assay was carried out in a 96-well plate with
monolayer DF-1 cells that were infected with 0.1 mL of
tenfold series dilutions of viral samples. The medium for
cultivation of H9N2 virus contained 0.25 lg/mL TPCK-
trypsin. After 4 days of incubation at 37 C, HA was tested
to measure the infectivity ratio for each individual dilution.
Then the TCID50 of virus was calculated using the standard
method of Reed and Muench [23].
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Replication kinetics
Viral replication kinetics experiments were performed on
the monolayers of DF-1 cells in 12-well plates (Corning,
China). Virus titers were determined by a HA assay and
then reported as TCID50. Briefly, 1 9 10
6 cells per well
were infected with either virus at MOIs of 1 (2 9 106
TCID50 in 0.1 mL), 0.1 (2 9 10
5 TCID50 in 0.1 mL), and
0.01 (2 9 104 TCID50 in 0.1 mL), respectively. The
medium for cultivation of H9N2 virus contained 0.25
lg/mL TPCK-trypsin. Culture supernatants were collected
at 0, 2, 12, 24, 36, 48, 60, and 72 h post-infection (pi),
respectively. After centrifugation at 2000 rpm (Sorvall
Legend Mach 1.6R, rotor 75003348) for 10 min to remove
cellular debris, samples were stored at -80 C until they
were further analyzed for TCID50. For every time point,
three independent assays were performed for both viruses
with each sample analyzed in triplicate.
RNA extractions from virus-infected cells
Adherent DF-1 cells were passaged 24 h before inocula-
tion. For each well, DF-1 cells were adjusted to 2.0 9 106
per well in 6-well plates (Corning, China) and then infected
with H5N1 and H9N2 virus at an MOI of 1 (4 9 106
TCID50 in 0.2 mL). After 1 h of incubation at 37 C and
5 % CO2 to allow virus adsorption, cells were washed once
with phosphate buffered saline (PBS) and further main-
tained at 37 C and 5 % CO2 in 2 mL of medium. The
medium for H9N2 virus cultivation contained 0.25 lg/mL
TPCK-trypsin. Cells were collected at multiple time points
following virus infection: 0, 3, 6, 9, 12, and 15 h, and total
RNAs were extracted from these samples for real-time RT-
PCR experiment. All infectious materials were handled
under the biosafety level 3 (BSL-3) condition.
Real-time RT-PCR
Total RNA was extracted from non-infected and infected
cells using an RNeasy Mini Kit (Axygen, China) following
the manufacturer’s instructions. Total RNA was converted
to cDNA using the ReverTra Ace qPCR RT Master Mix
with gDNA Remover (Toyobo, Japan). Real-time PCR was
carried out with 2 lL cDNA in a total 25 lL using SYBR
Green PCR Master Mix (Toyobo, Japan) on an ABI 7300
Real-Time System (Applied Biosystems, USA) following
provided instructions. Primers were designed based on
published sequences in NCBI database, and their accession
numbers are shown in Table 1. Primer pairs were selected
based on the specificity as determined by dissociation
curves. PCR conditions were the same for each targeted
gene amplification as follows: 95 C for 40 s, followed by
40 cycles of 95 C for 10 s, 55 C for 20 s, and 72 C for
20 s. An exception was that 53 C, not 55 C, was used as
Table 1 Primers used in
the study
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an annealing temperature for the amplification of KHSRP.
For every gene at each time point, four independent assays
were performed with each sample analyzed in triplicate.
The PCR products were detected on 1.5 % agarose gel and
used directly for sequencing in order to confirm the iden-
tities of the genes. The relative expression levels of the
target genes were analyzed using the 2-DDCt method [24].
Calculations and statistics
The house keeping gene b-actin was used as an internal
control, and quantification of the transcripts was performed
by the 2-DDCt method. All the primers have been verified
using the optimal real-time PCR conditions to ensure target
gene and b-actin amplified simultaneously. Each sub-
sequent time point (t = 3 h, 6, 9 h, 12 and 15 h hpi) was
compared against baseline (t = 0 h hpi) transcript level to
achieve DDCt. Logarithmic transformation of 2-DDCt was
performed on fold change values using Microsoft Excel
2007. Besides, the logarithmic transformation of 2-DCt
targets for every gene at different time points was used to
conduct statistical analysis of H5N1 or H9N2 transcripts.
Standard error was calculated according to the standard
method from four replicates of each gene tested. P value
\0.05, 0.01, and 0.001 was considered statistically sig-
nificant. Statistical analyses on the data obtained between 0
hpi and subsequent time points were performed using one-
way ANOVA of software program SPSS 17.0 (SPSS Inc.,
Illinois). Two-way ANOVA was employed to perform the
statistical analysis on the data obtained between H5N1 and
H9N2 viruses for each time point post-infection. All graphs
were accomplished using GraphPad Prism 5.
Results
Growth kinetics of H5N1 and H9N2 strains
with different MOIs
The kinetics of replication of H5N1 virus compared with
H9N2 virus were measured and compared for infectious
titers (TCID50) as a function of time. The data in Fig. 1
demonstrated that DF-1 supported the replication of both
H5N1 and H9N2 viruses, though the levels of virus pro-
duction between H5N1 and H9N2 viruses differed signifi-
cantly over time (p value \0.01). H5N1 virus replicated
efficiently, reaching up to 108.0 TCID50/mL at 24 h post-
infection. In contrast, H9N2 virus had a significantly lower
virus replication with peak virus titers reaching 104.5
TCID50/mL. Interestingly, dose-dependent effects on the
level of virus replication for both viruses were discernible
during the first 12 h of infection (p value \0.01), but the
effects were negligible beyond this time point during the
72-h period of replication kinetics experiment.
To determine the ratio of the infectious titer (i.e.,
TCID50) to HA unit for each virus stock used in previous
study, we performed HA assays. We found that H5N1 virus
had 107.33 TCID50 (0.1 mL) with HA titer 2
7, while H9N2
virus had 106.2 TCID50 (0.1 mL) with HA titer 2
6. The
relative ratio of TCID50 and HA unit in H5N1 virus was
about sevenfold higher than that observed in H9N2 virus.
This analysis indicated that H9N2 virus might produce
more defective particles than H5N1 virus, which warrants
future mechanistic investigation.
Analysis of differential expression patterns of immune-
defensive genes
Temporal analysis of differential expression of six
immune-defensive genes discriminated the host responses
from both viruses (Fig. 2; Table 2). We used one-way
ANOVA method to calculate statistical differences on the
data observed among different time points following
infection within each virus (H5N1 or H9N2), which was
shown in the top portion of each panel representing each
Fig. 1 Replication kinetics of H5N1 (1215 strain) and H9N2 (S2
strain) viruses in DF-1 cells. Monolayers of DF-1 cells were infected
with MOIs of 1, 0.1, and 0.01, respectively. The medium for H9N2
virus cultivation contained 0.25 lg/mL TPCK-trypsin. Culture super-
natants were collected at indicated time points. Virus titers were
determined by cytopathic effect (CPE) and reported as tissue culture
infectious dose (TCID50). Graphs represent mean ? SEM of three
independent experiments, each assayed in triplicate. Replication
kinetic curves of H9N2 and H5N1 viruses are indicated by a solid line
and a broken line with black color, respectively
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individual genes analyzed (Fig. 2). Two-way ANOVA
analysis was employed to analyze significant differences
on the data observed between H5N1 and H9N2 viruses on
the same time points following infection, which was
displayed in the bottom portion of each panel (Fig. 2).
This approach was also used in Fig. 3 to analyze another
set of gene expressions.
Among these genes analyzed, Mx1, ISG12, and OASL
genes had a similar response between DF-1 cells infected
with H5N1 and H9N2, respectively. These three genes
Fig. 2 Analysis of differential
expression of four immune-
defensive genes and IFN-a/b in
response to H5N1 and H9N2
infection. The genes tested in
this study included Mx1, OASL,
ISG12-2, IFIT5, and IFN-a/b.
For every target gene, the data
were normalized to b-actin
mRNA to achieve DCt. The
linear data from 2-DCt were
used for statistical analysis
using ANOVA method. The top
portion of each panel indicated
the data comparison (statistical
analysis with one-way ANOVA
method) among different time
points following infection
within each virus (H5N1 or
H9N2), while the bottom
portion displayed the data
comparison between H5N1 and
H9N2 viruses on the same time
points following infection
(statistical analysis with two-
way ANOVA method). Graphs
represent mean ? SEM of four
independent experiments with
each sample analyzed in
triplicate, (*), (**), and (***)
indicating significant difference
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were significantly upregulated starting at 6 or 9 h post-
infection and steadily rising until 15 h post-infection
(Fig. 2a–c; Table 2). Analysis of IFIT5 gene expression
revealed a slight difference in terms of host response
between two viruses. At early time points, IFIT5 gene
expression was similar in DF-1 cells infected by both
H5N1 and H9N2 viruses. However, at 15 hpi, a decline of
IFIT5 gene expression was observed in H5N1 infection
(p value \0.05, not shown in Fig. 2d). At this time point,
H9N2-infected cells exhibited a significant increase of
IFIT5 gene expression compared to those expressed at
early time points (p value \0.05) (Fig. 2d; Table 2). In
terms of the differential expression of IFN-a and IFN-b
genes, we found that both gene expressions were not
induced significantly at three time points (3, 6, and 9 hpi) in
virus-infected cells. However, after 9 hpi, a significant up-
regulation of IFN-a and IFN-b gene expression was
observed in cells infected by both viruses (Fig. 2e, f;
Table 2). This result indicated a strong ability of both
viruses in suppression of IFN genes expression at the early
stage of virus replication.
These results were also generally supported by two-way
ANOVA analysis focusing on the differences in host
response to H5N1 and H9N2 viruses. H5N1 infection in
DF-1 cells induced higher levels of Mx1 and OASL gene
expression than H9N2 infection at 15 hpi (p value \0.01)
(Fig. 2a, b). In terms of ISG12 gene, DF-1 cells infected
with H9N2 virus resulted in the level of its expression
higher than that in H5N1-infected cells with significant
difference at 12 and 15hpi (p value\0.01) (Fig. 2c), while
IFIT5 gene expression was distinct between two viruses in
terms of host response. For example, the expression of
IFIT5 gene reached the peak at 12hpi following H5N1
infection and declined significantly at 15 hpi, while at this
time point, H9N2 virus infection induced the most abun-
dant expression of IFIT5 gene in DF-1 cells with signifi-
cant difference compared to its expression in H5N1 virus-
infected cells (p value \0.001) (Fig. 2d). These ISGs
analyzed in this study consisted of Mx1, ISG12, OASL,
and IFIT5 that are downstream genes of IFN-a/b. Both
viruses induced a similar expression level of IFN-a and
IFN-b genes. IFN-b gene displayed similar expression
level without significant differences observed between two
viruses. However, an exception to above was H5N1 virus
that induced higher expression of IFN-a gene at 15 hpi than
its counterpart H9N2 virus in infected cells (p value
\0.001) (Fig. 2e, f)
Analysis of differential expression patterns of IRF7,
USP18, KHSRP, and SST
Analysis of the differential expression dynamics of four
immune-regulatory or immune-related genes resulted in
more diversified phenotypes in terms of the host responses
to two different subtypes of avian influenza virus (Fig. 3;
Table 3). A steady increase in the SST gene expression was
observed in DF-1 cells infected by both H5N1 and H9N2
viruses, though the differences were not statistically
Fig. 2 continued
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significant between these two viruses (Fig. 3a; Table 3).
Similar to IFIT5 expression pattern observed above that
could distinguish the two viruses, USP18 gene was also
significantly increased until 12 hpi followed by a marked
reduction at 15 hpi (p value\0.05)which occurred only in
H5N1-infected cells. A continuous increase in USP18 gene
expression was displayed at various time points following
H9N2 virus infection (Fig. 3b; Table 3). Remarkably, no
or little changes in the expression patterns of IRF7 and
KHSRP were observed in H5N1-infected DF-1 cells. In
contrast, a dynamic up-regulation of both genes was pres-
ent in DF-1 cells infected with H9N2 virus (Fig. 3a, d;
Table 3). Further comparison between the two viruses
demonstrated that KHSRP and IRF7 genes in H9N2 virus-
infected DF-1 cells displayed significantly high expressions
at 6, 9, 12, and 15 hpi, respectively, than their expression
levels in H5N1-infected cells (Fig. 3c, d). This is an
interesting finding in that the measurement of these two
genes can distinguish H5N1 and H9N2 viruses in terms of
the host response.
Table 2 Differential gene
expression infected with H5N1
















Mx1 0 1.00 1.27 0.79 1.00 1.46 0.69
3 1.49 1.00 2.22 1.30 1.88 0.90
6 3.4 2.29 5.05 3.24 4.72 2.22
9 3.1 2.49 3.78 5.68 7.44 4.33
12 6 4.11 8.69 4.87 6.63 3.57
15 9.2 6.13 13.69 5.48 7.99 3.76
OASL 0 1.00 0.6 1.68 1.00 1.49 0.68
3 1.46 0.87 2.46 1.27 1.78 0.90
6 1.59 1.00 2.51 2.79 4.12 1.89
9 3.91 2.40 6.41 8.08 11.34 5.76
12 7.06 4.86 10.27 9.33 13.12 6.64
15 32 20.68 49.52 19.87 30.79 12.82
ISG12-
2
0 1.00 0.72 1.39 1.00 1.42 0.7
3 1.34 1.01 1.78 1.59 2.21 1.14
6 2.32 1.30 4.12 3.48 4.67 2.59
9 4.24 2.86 6.30 10.06 13.77 7.34
12 8.97 6.04 13.32 23.18 33.50 16.00
15 13.5 9.78 18.77 31.56 44.03 22.60
IFIT5 0 1.00 0.74 1.36 1.00 1.33 0.75
3 2.18 1.50 3.18 2.18 2.75 1.73
6 4.0 2.93 5.47 2.71 3.45 2.13
9 8.65 6.12 12.23 6.90 9.29 5.13
12 10.43 6.42 16.94 7.12 8.91 5.70
15 7.12 4.87 10.43 13.27 16.7 10.52
IFN-a 0 1.00 1.65 0.60 1.00 1.38 0.73
3 1.10 1.60 0.75 0.71 1.20 0.42
6 1.47 2.28 0.95 1.85 2.96 1.16
9 1.73 2.52 1.18 2.07 2.86 1.50
12 15.49 23.70 10.12 10.21 13.58 7.67
15 63.12 94.50 42.16 26.48 36.59 19.16
IFN-b 0 1.00 1.52 0.66 1.00 1.36 0.74
3 0.47 0.66 0.34 0.88 1.27 0.61
6 1.49 2.11 1.06 3.99 10.72 1.48
9 3.27 4.52 2.36 4.01 5.68 2.84
12 9.75 13.27 7.17 18.09 25.77 12.70
15 80.47 116.86 55.41 41.78 60.35 28.92
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Discussion
Innate immunity provides a first line of defense against
pathogens and can be rapidly activated following viral
infection. Activation or response of ISGs might be different
against various pathogens or different strains of the same
pathogen such as influenza A virus. Using quantitative RT-
PCR for the analysis of a panel of innate immunity-related
genes, we observed some interesting antiviral responses
that can discriminate highly pathogenic H5N1 from low
Fig. 3 Analysis of differential
expression of four immune-
regulatory or immune-related
genes in response to H5N1 and
H9N2 infection. The genes
tested in this study included
USP18, IRF7, SST, and
KHSRP. For every target gene,
data were normalized to b-actin
mRNA to achieve DCt. The
linear data from 2-DCt were
used for statistical analysis
using ANOVA method. The top
portion of each panel indicated
the data comparison (statistical
analysis with one-way ANOVA
method) among different time
points following infection
within each virus (H5N1 or
H9N2), while the bottom
portion displayed the data
comparison between H5N1 and
H9N2 viruses on the same time
points following infection
(statistical analysis with two-
way ANOVA method). Graphs
represent mean ? SEM of four
independent experiments with
each sample analyzed in
triplicate, (*), (**), and (***)
indicating significant difference
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pathogenic H9N2 viruses in infected DF-1 cells. In this
study, mRNA samples collected at multiple time points
following virus infection were examined and compared for
the differential host gene responses to H5N1 and H9N2
viruses with a primary focus on a panel of immune-
defensive and immune-regulatory genes. Samples from
later time points beyond 15 h were not selected in our
study because infected DF-1 cells appeared cytopathic
effects (CPE) (data not shown).
IFN-stimulated effector genes including Mx1, OASL,
ISG12-2, and IFIT5 were selected in this study because
these genes are well characterized in the context of influ-
enza virus infection. IFN-a and IFN-b were also included
because they are upstream genes of these ISGs analyzed
and because of their ability to trigger a cascade of ISG
response that can directly interfere with influenza virus
replication. We also selected two immune-regulatory
genes, IRF7 and USP18, because of their roles in the
modulation of antiviral signaling pathways [13–16]. Two
additional genes included were K-homology splicing reg-
ulatory protein (KHSRP) and Somatostatin (SST) genes.
These two genes are believed to function as multifunctional
RNA-binding protein [25] and play roles in growth,
digestion (metabolism), and reproduction [26–29]. Inclu-
sion of these two genes in our analysis is due to the related
evidence showing that KHSRP had some roles in the reg-
ulation of NF-jB and the JAK2-STAT-1a pathways [30–
33], while SST functions in control growth, metabolism,
and reproduction of chicken [34], which are potentially
associated with influenza virus infection. In addition,
selection of DF-1 cells in this project was based on the fact
that it is susceptible to infection by both H5N1 and H9N2
subtypes of AIV [21, 22].
In this study, either virus induced a significant expres-
sion of IFN-a and IFN-b genes at 12 hpi or 15 hpi. It was
reported that influenza A could antagonist IFN-a/b induc-
tion in infected mammalian cells and avian cells via the
NS1 protein [35, 36], which may explain the delayed
induction of IFN-b. This observation coincided with the
appearance of CPE at 15 hpi and later time points in DF-1
cells, suggesting that either virus has disrupted the innate
immunity defense and subsequently established virus
infection.
A particular intriguing observation is that H9N2 virus
infection triggered a dynamic up-regulation of both
KHSRP and IRF-7, but their expressions were not altered
Table 3 Differential gene
expression infected with H5N1












SST 0 1.00 0.85 1.18 1.00 1.44 0.69
3 1.17 0.80 1.69 1.16 1.70 0.79
6 52.98 37.73 74.41 24.85 33.87 18.23
9 112.21 92.41 136.24 143.51 215.44 95.59
12 299.99 235.36 382.35 388.70 575.70 262.44
15 706.11 495.85 1005.54 1073.00 1499.78 767.73
USP18 0 1.00 0.76 1.32 1.00 1.27 0.79
3 1.25 0.79 1.98 1.21 1.49 0.98
6 2.18 1.49 3.19 1.26 1.51 1.05
9 2.65 2.07 3.40 1.85 2.49 1.38
12 3.63 2.27 5.82 2.24 2.75 1.82
15 1.87 1.34 2.61 2.65 3.25 2.16
KHSRP 0 1.00 0.74 1.36 1.00 1.31 0.77
3 0.99 0.75 1.29 1.05 1.30 0.85
6 1.05 0.74 1.49 3.23 3.93 2.66
9 1.34 1.02 1.76 1.96 2.50 1.54
12 1.55 0.99 2.45 7.39 9.15 5.96
15 2.27 1.73 2.97 10.50 13.39 8.23
IRF7 0 1.00 0.85 1.18 1.00 1.45 0.69
3 1.27 0.86 1.85 2.13 3.12 1.45
6 1.34 0.86 2.08 3.19 4.43 2.29
9 1.55 1.16 2.08 2.94 3.95 2.19
12 0.93 0.62 1.4 2.85 4.03 2.01
15 0.88 0.69 1.13 3.08 4.22 2.25
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in cells infected by H5N1 virus. The observed differential
gene expression between the two viruses could not attribute
to the different levels of virus replication because similar
expression cascades for Mx1, ISG12, SST, and OASL
genes were observed between H5N1- and H9N2-infected
cells. Expression of KHSRP was not responsive to H5N1
infection but had a strong induction after H9N2 infection,
suggesting that it plays a potential role in the replication
and pathogenesis of low pathogenic H9N2 virus infection.
KHSRP played some roles in p38MAPK, NF-jB, and
JAK2-STAT-1a pathways, and these signaling pathways
were reported to be in association with host defense of
avian influenza virus infection in avian-origin cells [30–33,
37, 38]. Induction of KHSRP gene expression may reflect a
feedback loop for which KHSRP stimulates IFN-a/b
secretion which in turn triggers downstream expression of
ISGs.
The similar expression pattern occurred in IRF7 gene
where its expression was significantly up-regulated in DF-1
cells infected by H9N2, not H5N1. IRF7 constitutes a part
of a positive feedback loop leading to the amplification of
IFN gene expression. Activated IRF7 cooperates with IRF3
and stimulates expression of the numerous IFN-related
genes leading to a broad IFN-a response in mammals.
Interestingly, the chicken genome does not encode IRF3
gene [39, 40]. We speculated that IRF7 alone in chicken
and other avian species might fulfill dual functions of
IRF3/IRF7 in mammals toward the induction of IFN-a/b
response. H5N1 virus infection induced little response of
IRF7 gene. In contrast, infection with H9N2 virus resulted
in a robust response of IRF7 in infected DF-1 cells. Similar
to possible subtype-specific KHSRP gene response, we
hypothesize that IRF7 plays an important role in the rep-
lication and pathogenesis of low pathogenic H9N2 virus,
which will be addressed in a future study.
The other interesting observation that can distinguish
two viruses includes IFIT5 and USP18 gene expression
patterns (Figs. 2d, 3b; Tables 2, 3). There was a continuous
upward increase for IFIT5 and USP18 genes until 12 hpi
followed by a significant decline at 15 hpi in H5N1 virus
infection. In contrast, a steady rise in both gene expressions
at various time points was observed in DF-1 cells infected
by H9N2 virus. Influence of these differential gene
expressions on viral pathogenesis needs to be further
investigated.
In summary, comparative analysis of innate immune
responses against high (H5N1) and low (H9N2) pathogenic
avian influenza A viruses in DF-1 cells revealed that the
responses of several selected genes (IFN-a, IFN-b, ISG12,
OASL, and SST) were similar between two viruses.
However, host responses to H5N1 and H9N2 viruses were
markedly different in two immune-regulatory genes
(KHSRP and IRF7). Our study showed a strong response to
H9N2 virus infection and no or little response to H5N1
virus infection. Results of our experiments shall provide
new information about the role of differential regulation of
innate immune response in modulation of viral virulence
and replication of different subtypes or strains of avian
influenza virus.
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